Genetic Susceptibility to Cancer: The Role of Polymorphisms in Candidate Genes
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
CONTEXT: Continuing advances in genotyping technologies and the inclusion of DNA collection in observational studies have resulted in an increasing number of genetic association studies. OBJECTIVE: To evaluate the overall progress and contribution of candidate gene association studies to current understanding of the genetic susceptibility to cancer. DATA SOURCES: We systematically examined the results of meta-analyses and pooled analyses for genetic polymorphisms and cancer risk published through March 2008. STUDY SELECTION: We identified 161 meta-analyses and pooled analyses, encompassing 18 cancer sites and 99 genes. Analyses had to meet the following criteria: include at least 500 cases, have cancer risk as outcome, not be focused on HLA antigen genetic markers, and be published in English. DATA EXTRACTION: Information on cancer site, gene name, variant, point estimate and 95% confidence interval (CI), allelic frequency, number of studies and cases, tests of study heterogeneity, and publication bias were extracted by 1 investigator and reviewed by other investigators. RESULTS: These 161 analyses evaluated 344 gene-variant cancer associations and included on average 7.3 studies and 3551 cases (range, 508-19 729 cases) per investigated association. The summary odds ratio (OR) for 98 (28%) statistically significant associations (P value <.05) were further evaluated by estimating the false-positive report probability (FPRP) at a given prior probability and statistical power. At a prior probability level of 0.001 and statistical power to detect an OR of 1.5, 13 gene-variant cancer associations remained noteworthy (FPRP <0.2). Assuming a very low prior probability of 0.000001, similar to a probability assumed for a randomly selected single-nucleotide polymorphism in a genome-wide association study, and statistical power to detect an OR of 1.5, 4 associations were considered noteworthy as denoted by an FPRP value <0.2: GSTM1 null and bladder cancer (OR, 1.5; 95% CI, 1.3-1.6; P = 1.9 x 10(-14)), NAT2 slow acetylator and bladder cancer (OR, 1.46; 95% CI, 1.26-1.68; P = 2.5 x 10(-7)), MTHFR C677T and gastric cancer (OR, 1.52; 95% CI, 1.31-1.77; P = 4.9 x 10(-8)), and GSTM1 null and acute leukemia (OR, 1.20; 95% CI, 1.14-1.25; P = 8.6 x 10(-15)). When the OR used to determine statistical power was lowered to 1.2, 2 of the 4 noteworthy associations remained so: GSTM1 null with bladder cancer and acute leukemia. CONCLUSION: In this review of candidate gene association studies, nearly one-third of gene-variant cancer associations were statistically significant, with variants in genes encoding for metabolizing enzymes among the most consistent and highly significant associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Self-citationFrosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
Hayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
Wacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,648
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Multiple loci identified in a genome-wide association study of prostate cancer
Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.91 · Cited by 900
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L. T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J. T., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1999 · Cited by 864
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
the CORGI Consortium, Tomlinson, I., Webb, E., Carvajal-Carmona, L., Broderick, P., Kemp, Z., Spain, S., Penegar, S., Chandler, I., Gorman, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2085 · Cited by 808
Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
Rebbeck, T. R. (1997) · PubMed · Cited by 729
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
Zanke, B. W., Greenwood, C. M., Rangrej, J., Kustra, R., Tenesa, A., Farrington, S. M., Prendergast, J., Olschwang, S., Chiang, T., Crowdy, E., et al. (2007) · Nature Genetics · doi:10.1038/ng2089 · Cited by 724
Self-citation(2000) · PubMed · Cited by 684
Multiple regions within 8q24 independently affect risk for prostate cancer
Haiman, C. A., Patterson, N., Freedman, M. L., Myers, S. R., Pike, M. C., Waliszewska, A., Neubauer, J., Tandon, A., Schirmer, C., McDonald, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2015 · Cited by 663
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67137-1 · Cited by 627
A common coding variant in CASP8 is associated with breast cancer risk
The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Cox, A., on behalf of the Breast Cancer Association Consortium, Dunning, A. M., Garcia-Closas, M., Balasubramanian, S., Reed, M. W. R., Pooley, K. A., Scollen, S., Baynes, C., et al. (2007) · Nature Genetics · doi:10.1038/ng1981 · Cited by 610
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Hung, R. J., Hall, J., Brennan, P., & Boffetta, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi318 · Cited by 525
Hein, D. W. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00153-7 · Cited by 518
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk
members of the CORGI Consortium, Broderick, P., Carvajal-Carmona, L., Pittman, A. M., Webb, E., Howarth, K., Rowan, A., Lubbe, S., Spain, S., Sullivan, K., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.18 · Cited by 514
Meta-analysis: State-of-the-Science
Dickersin, K., & Berlin, J. A. (1992) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036084 · Cited by 498
Folate Status: Effects on Pathways of Colorectal Carcinogenesis
Choi, S.-W., & Mason, J. B. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2413s · Cited by 398
Hayes, J. D., & Strange, R. C. (1995) · Free Radical Research · doi:10.3109/10715769509147539 · Cited by 395
Rothman, N., Skibola, C. F., Wang, S. S., Morgan, G., Lan, Q., Smith, M. T., Spinelli, J. J., Willett, E., De Sanjose, S., Cocco, P., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70434-4 · Cited by 381
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J. T., Manolescu, A., Gudbjartsson, D., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Blondal, T., et al. (2008) · Nature Genetics · doi:10.1038/ng.89 · Cited by 370
A common genetic risk factor for colorectal and prostate cancer
Haiman, C. A., Le Marchand, L., Yamamato, J., Stram, D. O., Sheng, X., Kolonel, L. N., Wu, A. H., Reich, D., & Henderson, B. E. (2007) · Nature Genetics · doi:10.1038/ng2098 · Cited by 365
Rozen, R. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657581 · Cited by 363
Low P-Values or Narrow Confidence Intervals: Which Are More Durable?
Poole, C. (2001) · Epidemiology · doi:10.1097/00001648-200105000-00005 · Cited by 350
Nelson, H. H., Wiencke, J. K., Christiani, D. C., Cheng, T. J., Zuo, Z.-F., Schwartz, B. S., Lee, B.-K., Spitz, M. R., Wang, M., Xu, X., et al. (1995) · Carcinogenesis · doi:10.1093/carcin/16.5.1243 · Cited by 342
Weischer, M., Bojesen, S. E., Ellervik, C., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5922 · Cited by 306
Morgan, T. M., Krumholz, H. M., Lifton, R. P., & Spertus, J. A. (2007) · JAMA · doi:10.1001/jama.297.14.1551 · Cited by 270
Duggan, D., Zheng, S. L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F., Robbins, C., Isaacs, S. D., Cheng, Y., Li, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm250 · Cited by 254
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
de Jong, M. M., Nolte, I. M., te Meerman, G. J., van der Graaf, W. T. A., Oosterwijk, J. C., Kleibeuker, J. H., Schaapveld, M., & de Vries, E. G. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.225 · Cited by 235
Lewis, S. J., & Davey Smith, G. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0196 · Cited by 235
Understanding research synthesis (meta-analysis).
Mosteller, F., & Colditz, G. A. (1996) · Annual Review of Public Health · doi:10.1146/annurev.pu.17.050196.000245 · Cited by 228
De Ruyck, K., Szaumkessel, M., De Rudder, I., Dehoorne, A., Vral, A., Claes, K., Velghe, A., Van Meerbeeck, J., & Thierens, H. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2007.03.010 · Cited by 212
Kiyohara, C., & Yoshimasu, K. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.59 · Cited by 187
Kiyohara, C., Takayama, K., & Nakanishi, Y. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.08.009 · Cited by 181
Low-penetrance genes and their involvement in colorectal cancer susceptibility.
de Jong, M. M., Nolte, I. M., Meerman, G. J. T., van der Graaf, W. T. A., de Vries, E. G. E., Sijmons, R. H., Hofstra, R. M. W., & Kleibeuker, J. H. (2002) · PubMed · Cited by 164
Ye, Z., & Song, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.014 · Cited by 162
Betting Odds and Genetic Associations
Thomas, D. C., & Clayton, D. G. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh094 · Cited by 158
López-Cima, M. F., González-Arriaga, P., García-Castro, L., Pascual, T., Marrón, M. G., Puente, X. S., & Tardón, A. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-162 · Cited by 155
Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review
Raimondi, S., Paracchini, V., Autrup, H. N., Barros-Dios, J. M., Benhamou, S., Boffetta, P., Coté, M. L., Dialyna, I., Dolžan, V., Filiberti, R., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj321 · Cited by 150
Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer
Zhang, Y., Newcomb, P. A., Egan, K. M., Titus-Ernstoff, L. T., Chanock, S. J., Welch, R. A., Brinton, L. A., Lissowska, J., Bardin‐Mikolajczak, A., Pepłońska, B., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0653 · Cited by 149
P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature
Zhou, Y., Li, N., Zhuang, W., Liu, G., Wu, T., Yao, X., Du, L., Wei, M., & Wu, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22833 · Cited by 142
Zeegers, M. P., Kiemeney, L. A. L. M., Nieder, A. M., & D, H. O. M. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1765.13.11 · Cited by 132
Tracking the Epidemiology of Human Genes in the Literature: The HuGE Published Literature Database
Lin, B. K., Clyne, M., Walsh, M., Gomez, O., Yu, W., Gwinn, M., & Khoury, M. J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj175 · Cited by 128
Boccia, S., Hung, R. J., Ricciardi, W., Gianfagna, F., Ebert, M., Fang, J., Gao, C., Götze, T., Graziano, F., Lacasaña‐Navarro, M., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm344 · Cited by 116
MDM2 SNP309 and cancer risk: a combined analysis
Wilkening, S., Bermejo, J. L., & Hemminki, K. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm191 · Cited by 113
Chao, C., Zhang, Z., Berthiller, J., Boffetta, P., & Hashibe, M. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0899 · Cited by 112
CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis
Shi, X., Zhou, S., Wang, Z., Zhou, Z., & Wang, Z. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.08.004 · Cited by 111
Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis
Gorouhi, F., Islami, F., Bahrami, H., & Kamangar, F. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604277 · Cited by 110
Rostami‐Hodjegan, A., Lennard, M. S., Woods, H. F., & Tucker, G. T. (1998) · Pharmacogenetics · doi:10.1097/00008571-199806000-00005 · Cited by 108
MTHFR C677T and colorectal cancer risk: A meta‐analysis of 25 populations
Hubner, R. A., & Houlston, R. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22440 · Cited by 106
Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk
Figueroa, J. D., Malats, N., Rothman, N., Real, F. X., Silverman, D. T., Kogevinas, M., Chanock, S. J., Yeager, M., Welch, R. A., Dosemeci, M., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm132 · Cited by 105
Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression
Bolufer, P., Barragán, E., Collado, M., Cervera, J., López, J.-A., & Sanz, M. Á. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.01.016 · Cited by 104
Huang, Y., Han, S., Li, Y., Mao, Y., & Xie, Y. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0082-5 · Cited by 99
Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells
Rosfjord, E. C., & Dickson, R. B. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018789527533 · Cited by 98
Association of interleukin‐1 gene polymorphisms with gastric cancer: A meta‐analysis
Wang, P., Xia, H. H., Zhang, J., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22353 · Cited by 98
Clavel, J., Goujon, S., Rebouissou, S., Ménégaux, F., Feunteun, J., Bonaïti‐Pellié, C., Baruchel, A., Kébaïli, K., Lambilliotte, A., Leverger, G., et al. (2005) · European Journal of Cancer Prevention · doi:10.1097/00008469-200512000-00007 · Cited by 97
DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case–control studies
Han, S., Zhang, H., Wang, Z., Xie, Y., Tang, R., Mao, Y., & Li, Y. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201681 · Cited by 97
Bolufer, P., Collado, M. V., Barragán, E., Cervera, J., Calasanz, M. J., Colomer, D., Román‐Gómez, J., & Sanz, M. Á. (2007) · Haematologica · doi:10.3324/haematol.10752 · Cited by 91
Sanderson, S., Salanti, G., & Higgins, J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm167 · Cited by 91
Gayther, S. A., Song, H., Ramus, S. J., Kjær, S. K., Whittemore, A. S., Quaye, L., Tyrer, J. P., Shadforth, D., Høgdall, E. V. S., Høgdall, C. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3261 · Cited by 90
TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies
Pasche, B., Kaklamani, V., Hou, N., Young, T., Rademaker, A., Peterlongo, P., Ellis, N., Offit, K., Caldes, T., Reiss, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.271 · Cited by 88
Structure and chromosome localization of the human CASP8 gene
Grenet, J. A., Teitz, T., Wei, T., Valentine, V. A., & Kidd, V. J. (1999) · Gene · doi:10.1016/s0378-1119(98)00565-4 · Cited by 88
Paracchini, V., Raimondi, S., Gram, I. T., Kang, D., Kocabaş, N. A., Kristensen, V. N., Li, D., Parl, F. F., Rylander‐Rudqvist, T., Souček, P., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj365 · Cited by 83
DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies
Wang, F., Chang, D. K., Hu, F., Sui, H., Han, B., li, D.-D., & Zhao, Y. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2507 · Cited by 76
Phase I/II enzyme gene polymorphisms and esophageal cancer risk: A meta-analysis of the literature
Yang, C.-X. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i17.2531 · Cited by 76
Kellen, E., Hemelt, M., Bröberg, K., Golka, K., Kristensen, V. N., Hung, R. J., Matullo, G., Mittal, R., Porru, S., Povey, A. C., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm003 · Cited by 75
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma
Bethke, L., Webb, E. L., Murray, A., Schoemaker, M. J., Johansen, C., Christensen, H. C., Muir, K. R., McKinney, P. A., Hepworth, S. J., Dimitropoulou, P., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm351 · Cited by 74
XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis
Francisco, G., Menezes, P. R., Eluf‐Neto, J., & Chammas, R. J. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.6 · Cited by 70
Vineis, P., Veglia, F., GARTE, S. J., MALAVEILLE, C., Matullo, G., Dunning, A. M., Peluso, M. E. M., Airoldi, L., Overvad, K., Raaschou‐Nielsen, O., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm109 · Cited by 68
Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma
Brenner, A. V., Butler, M. A., Wang, S., Ruder, A. M., Rothman, N., Schulte, P. A., Chanock, S. J., Fine, H. A., Linet, M. S., & Inskip, P. D. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm210 · Cited by 65
Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma
Bethke, L., Murray, A., Webb, E. L., Schoemaker, M. J., Muir, K. R., McKinney, P. A., Hepworth, S. J., Dimitropoulou, P., Lophatananon, A., Feychting, M., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn004 · Cited by 64
Little, J., Sharp, L., Masson, L. F., Brockton, N. T., Cotton, S. C., Kingsbury, N., & Cassidy, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22093 · Cited by 63
RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis
Li, H., & Tai, B. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2799 · Cited by 63
Setiawan, V. W., Schumacher, F. R., Haiman, C. A., Stram, D. O., Albanes, D., Altshuler, D., Berglund, G. L., Buring, J. E., Calle, E. E., Clavel‐Chapelon, F., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0589 · Cited by 62
A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk
Zhang, D., Chen, C., Fu, X., Gu, S., Mao, Y., Xie, Y., Huang, Y., & Li, Y. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0215-5 · Cited by 61
Genetic variability in inflammation pathways and prostate cancer risk
Sun, J., Turner, A. R., Xu, J., Grönberg, H., & Isaacs, W. B. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.10.001 · Cited by 58
García‐Closas, M., Kristensen, V. N., Langerød, A., Qi, Y., Yeager, M., Burdett, L. A., Welch, R. A., Lissowska, J., Pepłońska, B., Brinton, L. A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22985 · Cited by 58
Taioli, E., Benhamou, S., Bouchardy, C., Cascorbi, I., Cajas‐Salazar, N., Dally, H., Fong, K. M., Larsen, J. E., Marchand, L. L., London, S. J., et al. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31803068b1 · Cited by 57
Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature
Boccia, S., Torre, G. L., Gianfagna, F., Mannocci, A., & Ricciardi, G. (2006) · Mutagenesis · doi:10.1093/mutage/gel005 · Cited by 56
TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study
Cox, D. G., Penney, K. L., Guo, Q., Hankinson, S. E., & Hunter, D. J. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-175 · Cited by 56
Sigurdson, A. J., Bhatti, P., Doody, M. M., Hauptmann, M., Bowen, L., Simon, S. L., Weinstock, R. M., Linet, M. S., Rosenstein, M., Stovall, M. A., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0282 · Cited by 54
One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
Lee, K.-M., Lan, Q., Kricker, A., Purdue, M. P., Grulich, A. E., Vajdic, C. M., Turner, J., Whitby, D., Kang, D., Chanock, S. J., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0431-2 · Cited by 46
Shook, S. J., Beuten, J., Torkko, K. C., Johnson‐Pais, T. L., Troyer, D. A., Thompson, I. M., & Leach, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0702 · Cited by 44
Tan, X., Nieters, A., Kropp, S., Hoffmeister, M., Brenner, H., & Chang-Claude, J. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23363 · Cited by 39
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk
Liu, G., Wheatley‐Price, P., Zhou, W., Park, S., Heist, R. S., Asomaning, K., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23178 · Cited by 39
Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer
Tripathy, C. B., & Roy, N. (2005) · Head & Neck · doi:10.1002/hed.20295 · Cited by 38
Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis
Chen, C., Huang, Y., Li, Y., Mao, Y., & Xie, Y. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0131-8 · Cited by 36
Meta-analysis in cancer epidemiology.
Morris, R. D. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s861 · Cited by 36
Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
Onay, U. V., Aaltonen, K., Briollais, L., Knight, J. A., Pabalan, N., Kilpivaara, O., Andrulis, I. L., BLOMQVIST, C. P., Nevanlinna, H. A., & Özçelik, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-6 · Cited by 34
RNASEL and RNASEL‐inhibitor variation and prostate cancer risk in Afro‐Caribbeans
Shea, P. R., Ishwad, C. S., Bunker, C. H., Patrick, A. L., Kuller, L. H., & Ferrell, R. E. (2008) · The Prostate · doi:10.1002/pros.20687 · Cited by 27
Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis
Ye, Z., Song, H., & Guo, Y. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016246 · Cited by 24
Haiman, C. A., Setiawan, V. W., Xia, L. Y., Marchand, L. L., Ingles, S. A., Ursin, G., Press, M. F., Bernstein, L., John, E. M., & Henderson, B. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4801 · Cited by 22
Glutathione S -transferase T1 polymorphisms are associated with outcome in colorectal cancer
Rajagopal, R., Deakin, M., Fawole, A. S., Elder, J. B., Elder, J. B., Smith, V., Strange, R. C., & Fryer, A. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi195 · Cited by 16
Cited by
Alengebawy, A., Abdelkhalek, S. T., Qureshi, S. R., & Wang, M.-Q. (2021) · Toxics · doi:10.3390/toxics9030042 · Cited by 2,339
Hazardous effects of chemical pesticides on human health–Cancer and other associated disorders
Sabarwal, A., Kumar, K., & Singh, R. P. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.08.018 · Cited by 658
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
“In a systematic review of 161 meta-analyses and pooled analyses of SNPs in 99 candidate genes in 18 cancer sites, nearly one-third (98/344) of gene variants were significantly associated with cancer, including 6 cytokine gene variant”
BackgroundGermline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
Metadata
- Authors
- Dong, L. M., Potter, J. D., White, E., Ulrich, C. M., Cardon, L. R., & Peters, U.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-05-28
- Volume
- 299
- Issue
- 20
- Pages
- 2423
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2126928020
- Cited by
- 461
- References
- 103
- FWCI
- 24.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.